Clinical Trials Browser

Interventional × donafenib × Thoracic × Clear all

NCT04059874 2019-08-16

Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung